HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 5 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,821,193 | -19.1% | 109,636 | -23.1% | 0.59% | -9.9% |
Q2 2023 | $12,132,620 | +2.9% | 142,502 | 0.0% | 0.66% | -5.6% |
Q1 2023 | $11,792,041 | +7.4% | 142,502 | +2.1% | 0.70% | +2.5% |
Q4 2022 | $10,981,270 | -44.3% | 139,622 | -47.6% | 0.68% | -45.5% |
Q3 2022 | $19,726,000 | +7.4% | 266,463 | -5.5% | 1.25% | +17.1% |
Q2 2022 | $18,374,000 | +31.1% | 281,893 | +27.1% | 1.06% | +71.8% |
Q1 2022 | $14,020,000 | +123.6% | 221,768 | +216.8% | 0.62% | +109.5% |
Q2 2020 | $6,270,000 | -73.3% | 70,013 | -70.3% | 0.30% | -79.9% |
Q1 2020 | $23,494,000 | -14.5% | 235,740 | -1.5% | 1.47% | +31.2% |
Q4 2019 | $27,489,000 | +21.8% | 239,240 | +33.7% | 1.12% | +12.4% |
Q3 2019 | $22,576,000 | +12.6% | 178,977 | +7.4% | 1.00% | +25.5% |
Q2 2019 | $20,051,000 | +58.2% | 166,617 | +15.0% | 0.80% | +56.7% |
Q1 2019 | $12,678,000 | +5.2% | 144,927 | +20.3% | 0.51% | -9.8% |
Q4 2018 | $12,049,000 | – | 120,427 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |